Pure Global

FT3 Rapid Quantitative Test - India CDSCO Medical Device Registration

FT3 Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000035_0bb0dc8998e35cfbc94703f50022d71d_4097a5ae2bde4c751b1640e98775aebb. This device is marketed under the brand name Immunoglobulin E. The license holder is DIYA SCIENTIFIC, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
FT3 Rapid Quantitative Test
UID: IMP/IVD/2022/000035_0bb0dc8998e35cfbc94703f50022d71d_4097a5ae2bde4c751b1640e98775aebb

Brand Name

Immunoglobulin E

License Holder

DIYA SCIENTIFIC

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Biotime FT3 Rapid Quantitative Test is intended to quantify the concentration of FT3 in human serum on Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid detection of hyperthyroidism. -Fluorescence immunoassay -hyperthyroidism For in vitro diagnostic use only. For professional use only

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing